Knowledge gaps and acquisition about HPV and its vaccine among Brazilian medical students

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS ONE, v.15, n.3, article ID e0230058, 16p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To analyze factors associated with knowledge gaps and acquisition about HPV and its vaccine among medical students. Method Cross-sectional and analytical study conducted at the University of Sao Paulo Medicine School, in 2016. A convenience sample of students completed a data collection instrument containing questions on knowledge about HPV and its vaccine, and vaccine acceptability. The level of knowledge and acceptability established as a ""good level"" was 80% of correct answers on the questionnaire. Internal validity was calculated with Cronbach's alpha value (alpha) = 0.74. Bivariate and multiple analyzes were performed using the Stata (R) program (Stata Corp, College Station, USA) 14.0. Results To evaluate the internal consistency of the instrument applied, the Cronbach's alpha equation was used, obtaining the alpha value (alpha) = 0.74 for this population. This value attests that the consistency of the answers obtained with this questionnaire is considered substantial and acceptable. Among the 518 medical students who completed the survey, the majority were men 312 (60.4%) with a mean age of 23 (+/- 2.8) years old; 199 (38.3%) of the students were in the final years of graduation (5th and 6th years). Students in the first, second and third year of study had a 51% higher risk of a knowledge gap when compared to students in the final years of graduation [PR 1.51 (1.3:1.8); p < 0.001]. Men were at 22% higher risk of unsatisfactory knowledge than women are [PR 1.22 (1.07: 1.39). There was no knowledge acquisition during medical school in the following questions (p < 0.05), indication of vaccine for individuals with HIV and contraindication in pregnant patients. Conclusion Male medical students, in the first year of medical school, and those who were not vaccinated had significant knowledge gaps about HPV. The novelty of the study includes the finding of non- acquisition of knowledge during the medical school graduation on safety and vaccination schedule and vaccine administration in specific populations.
Palavras-chave
Referências
  1. Agranonik M, 2011, CLIN BIOMEDICAL RES, V31
  2. [Anonymous], 2019, LANCET CHILD ADOLESC, V3, P281, DOI 10.1016/S2352-4642(19)30092-6
  3. Berenson AB, 2015, HUM VACC IMMUNOTHER, V11, P1331, DOI 10.1080/21645515.2015.1022691
  4. Bianco A, 2019, VACCINE, V37, P984, DOI 10.1016/j.vaccine.2018.12.062
  5. Bianco A, 2014, HUM VACC IMMUNOTHER, V10, P2536, DOI 10.4161/21645515.2014.969614
  6. Bowyer HL, 2013, VACCINE, V31, P1051, DOI 10.1016/j.vaccine.2012.12.038
  7. Brasil. Ministerio da Saude, 2018, 135SEI2017CGPNIDEVIT
  8. Brotherton JML, 2018, BEST PRACT RES CL OB, V47, P42, DOI 10.1016/j.bpobgyn.2017.08.010
  9. Brotherton JML, 2016, MED J AUSTRALIA, V204, P184, DOI 10.5694/mja15.01038
  10. Chen JM, 2016, AM INT J SOC SCI, V3, P56
  11. Chernyshov PV, 2019, ACTA DERMATOVEN ALP, V28, P75, DOI 10.15570/actaapa.2019.19
  12. Cinar IO, 2019, ASIA-PAC J ONCOL NU, V6, P300, DOI 10.4103/apjon.apjon_10_19
  13. D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809
  14. Gilkey MB, 2016, HUM VACC IMMUNOTHER, V12, P1454, DOI 10.1080/21645515.2015.1129090
  15. Pereira JEG, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e1166
  16. Haverkos H, 2000, BIOMED PHARMACOTHER, V54, P54, DOI 10.1016/S0753-3322(00)88642-4
  17. Head KJ, 2013, PUBLIC HEALTH NURS, V30, P351, DOI 10.1111/phn.12044
  18. Instituto Nacional de Cancer (INCA/MS), CONTR CANC COL UT CO
  19. Koc Z, 2015, J AM COLL HEALTH, V63, P13, DOI 10.1080/07448481.2014.963107
  20. Kwan TTC, 2008, SEX TRANSM INFECT, V84, P227, DOI 10.1136/sti.2007.029363
  21. Kwang NB, 2014, ASIAN PAC J CANCER P, V15, P9117, DOI 10.7314/APJCP.2014.15.21.9117
  22. LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
  23. Machalek DA, 2018, J INFECT DIS, V217, P1590, DOI 10.1093/infdis/jiy075
  24. Makwe CC, 2012, J EPIDEMIOL GLOB HEA, V2, P199, DOI 10.1016/j.jegh.2012.11.001
  25. Malo TL, 2014, CANCER EPIDEM BIOMAR, V23, P2126, DOI 10.1158/1055-9965.EPI-14-0344
  26. Markowitz LE, 2014, MMWR RECOMM REP, V63, P1
  27. McRee AL, 2014, J PEDIATR HEALTH CAR, V28, P541, DOI 10.1016/j.pedhc.2014.05.003
  28. Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943
  29. Napolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271
  30. Niccolai LM, 2015, JAMA PEDIATR, V169, P686, DOI 10.1001/jamapediatrics.2015.0310
  31. Ortashi O, 2013, VACCINE, V31, P5141, DOI 10.1016/j.vaccine.2013.08.016
  32. Rajiah Kingston, 2015, VirusDisease, V26, P297, DOI 10.1007/s13337-015-0287-3
  33. Rosberger Z, 2014, J CANCER EDUC, V29, P473, DOI 10.1007/s13187-013-0572-z
  34. Sherman SM, 2016, J OBSTET GYNAECOL, V36, P76, DOI 10.3109/01443615.2015.1041886
  35. Silva GM, 2016, REV HUPE RIO DE JANE, V15, P328
  36. Silva SL, 2017, SAUDE SANTA MARIA, V43, P125
  37. Sorpreso ICE, 2018, J HUM GROWTH DEV, V28, P5, DOI [10.7322/jhgd.143887, DOI 10.7322/JHGD.143887]
  38. Sorpreso ICE, 2020, MED STUDENTS HPV KNO, DOI [10.7910/DVN/IR3UJO, DOI 10.7910/DVN/IR3UJO]
  39. Sousa PDL, 2018, J HUM GROWTH DEV, V28, P58, DOI [10.7322/jhgd.143856, DOI 10.7322/JHGD.143856]
  40. Uzunlar O, 2013, VACCINE, V31, P2191, DOI 10.1016/j.vaccine.2013.01.033
  41. Williams WW, 2013, VACCINE, V31, P2937, DOI 10.1016/j.vaccine.2013.04.041
  42. World Health Organization, 2017, HUM PAP VACC WHO POS
  43. World Health Organization (WHO), 2017, CANC DIAGN SCREEN CE, V92, P241
  44. Yam Pui Woo Angela, 2017, Asian Pac J Cancer Prev, V18, P1689
  45. Yoruk S, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0330-6
  46. Zouheir Y, 2016, J PEDIATR ADOL GYNEC, V29, P292, DOI 10.1016/j.jpag.2015.11.002